PADI4 and chronic obstructive pulmonary disease: Previous reports have demonstrated similarities between murine and human COPD pathophysiology [77], supporting the biological significance of our findings; however, additional work is needed to assess whether PAD4 inhibition and NET-targeting strategies yield comparable effects in human disease contexts.